Recently, the Competition and Enforcement Bureau of the State Administration for Industry and Commerce held a typical case analysis of commercial bribery in some provinces, autonomous regions and municipalities in Hefei, Anhui Province. The law enforcement backbones from 12 provinces, autonomous regions, municipalities and municipalities including Chongqing, Jilin, Shandong, Anhui, Fujian and Xinjiang attended the meeting. The meeting discussed two cases of medicine purchase and sale in Hebei and Hubei.
This meeting focused on the field of pharmaceutical purchase and sale, and discussed whether it would constitute a commercial bribe, such as the payment of quality guarantee and performance bond beyond a reasonable range. In the end, a consensus was reached on commercial bribery in the field of medicine purchase and sale, which will set off a wave of anti-corruption in hospitals.
1. The core of hospital corruption: the purchase and sale of bribes
Commercial bribery cases in the field of medicine purchase and sale have been difficult to investigate and deal with by industry and commerce and market supervision departments due to complicated cases and cross-legting issues. In addition, commercial bribery cases in the field of medicine purchase and sale have the characteristics of large amount, diversified means and strong concealment. It also poses challenges for industrial and commercial authorities to investigate such cases.
Recalling the GSK case, from July 2013 to September 2014, the state imposed a fine of 3 billion yuan on GlaxoSmithKline (China) Investment Co., Ltd., due to the complicated case, the huge amount involved, and the concealment. When it came to the application of the law, the people involved, and the wide range of cases involved, the industry and commerce, supervision and public security departments and other departments took more than a year to pronounce their judgments.
Nowadays, corruption has become a core issue in China's medical system, and the stakes associated with corruption have become the crux of how to break commercial bribery in the field of pharmaceutical purchases and sales.
This meeting focused on the field of pharmaceutical purchase and sale, and discussed whether it would constitute a commercial bribe, such as the payment of quality guarantee and performance bond beyond a reasonable range. It is unanimously considered that it is reasonable and reasonable for the hospital to collect reasonable insurance premiums and performance bonds from pharmaceutical companies and pharmaceutical distribution companies. The reasonable range is generally about 10% of the contract amount during the procurement period. The high-quality insurance premium and performance bond that violate the general business practices, the huge interest of the suffocation will induce the two parties to conduct improper transactions, suspected of using high-quality insurance and performance bond as the name of commercial bribery.
The meeting of the Ministry of Industry and Commerce played an active role in promoting the exchange of law enforcement business and raising the level of law enforcement and handling cases, especially in the commercial bribery in the field of pharmaceutical purchase and sale, which provided a strong basis for the investigation of such cases.
2. Multiple ministries and commissions jointly attacked and rushed to control the purchase and sale of bribes
An important point of hospital involvement in corruption is the purchase and sale of bribes in medicine, which has become the front line of hospital anti-corruption. To this end, on March 20, the Health and Family Planning Commission, the Ministry of Development and Reform Commission, the Ministry of Industry and Information Technology, the Ministry of Finance, the Ministry of Commerce, the Trade and Industry Bureau, the Taxation Bureau, the Food and Drug Administration and other ministries and commissions convened the "correction of the purchase and sale of medical care and medical services in the inter-ministerial joint At the 17th meeting of the conference, the focus was on punishing commercial bribery in the field of medicine purchase and sale. Li Bin, director of the Shanghai Municipal Health Planning Commission, asked: On the one hand, we must continue to maintain the high-pressure situation of investigating cases, and thoroughly manage commercial bribery in the field of pharmaceutical purchases and sales; on the other hand, we must deepen reforms, strengthen the construction of the supervision system, and promote the fundamental improvement of the industry. In addition, at the previous National Conference on Drug Administration, Sun Zhigang, deputy director of the Health Planning Commission, said that this year will unify the construction standards for provincial drug centralized procurement platforms and promote the standardization of drug procurement codes.
Zhu Bin, deputy director of the Anhui Provincial Administration for Industry and Commerce, said that since last year, Anhui Province’s industrial and commercial system has filed a case for investigating commercial bribery, involving 27 cases in the field of pharmaceutical purchase and sale. After the outbreak of 16 hospital directors, the 27 cases in Anhui were highly representative. It can be found that the current bribery incident in the field of drug purchase and sale in the country is still very serious, and it is necessary to intensify efforts to crack down on bribery in medicine purchase and sale.
The Party Group of the National Health Planning Commission decided to conduct 4 rounds of patrols in 2015, with 3 to 4 units per round. At present, all the four inspection teams in the first round of inspections have been stationed in the patrol units. Recently, the whole army carried out special rectification actions for medical ethics and medical treatment, and the anti-corruption curtain of military hospitals was opened, focusing on the investigation of corruption incidents in the procurement of pharmaceutical equipment.
3. Anti-corruption new normal
With the tigers and flies being photographed in succession, anti-corruption has become a new normal; and the pharmaceutical industry, which is implicated in people's life and health, has made the bribery behavior diversified and concealed because of its uniqueness. It has become a difficult point and key point in anti-corruption.
In January, the Supervision Bureau of the Discipline Inspection Group of the Ministry of Supervision of the Central Commission for Discipline Inspection informed that eight hospital cadres received bribes and received kickbacks.
In February, due to the receipt of kickbacks, various "hidden rules" prevailed, and the heads of 16 public hospitals in Anhui fell. Individual cities even experienced "collapse" corruption.
In March, the Health Planning Commission and a number of ministries and commissions focused on punishing commercial bribery in the field of medicine purchase and sale.
4. In April, the General Administration of Industry and Commerce gave a clear identification of the bribes for the purchase and sale of medicines.
The Health Planning Commission has carried out the first round of patrols, and the military hospitals have also launched a special campaign for medical ethics.
Statistics: In 2014, more than 20 hospital directors across the country were investigated by the Commission for Discipline Inspection or have entered the judicial process. Hainan, Anhui, Sichuan, Jiangxi, Hunan and other places have successively detected a number of corruption cases in the medical and health system. Among them, the corruption case in the purchase and sale of Zhangzhou Medicine involved more than 70 people; 14 core hospitals in Hainan due to medical commercial bribery Being involved; due to the receipt of kickbacks, various "hidden rules" prevailed, and 16 public hospital deans in Anhui have fallen, and individual cities have even experienced "collapse" corruption.
In 2015, the anti-corruption efforts in the medical field will only increase!
Upright Safe,Hotel Upright Safe Box,Hotel Digital Safe Box,Electric Hotel Digital Safe Box
Hebei Hupai Aodi Cabinet Industry Co.,Ltd. , https://www.hupaiaodi.com